Keywords: GlaxoSmithKline, Daiichi Sankyo, Vaccines joint venture, Japan

GSK and Daiichi Sankyo set up Japanese vaccines JV

Article | 02 March 2012

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) says it has signed an agreement with Japan’s third-largest drugmaker Daiichi Sankyo ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in